این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Heart Journal، جلد ۲۵، شماره ۳، صفحات ۳۵-۵۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی The Effect of the COVID-19 Pandemic on Post-PCI Outcomes: A Study of First Event Occurrences
چکیده انگلیسی مقاله Background: Previous studies have reported a higher incidence of ischemic events in African Americans (AAs) than in non-AAs following percutaneous coronary intervention (PCI). Moreover, AAs are known to experience worse COVID-19-related outcomes. However, the impact of the COVID-19 pandemic on the first occurrence of ischemic events among race and gender-stratified post-PCI patients remains unknown.   Methods: In this retrospective study, we compared patient demographics and the first adverse events post-PCI before (2018-2020) and during (2020-2021) the COVID-19 pandemic. Continuous variables were expressed as mean ± standard deviation and compared using the 2-sample t-test, while categorical variables were compared using the χ2 test. Univariate and multivariate logistic regression analyses were performed using Stata17 software.   Results: The study population consisted of 1022 patients, with 511 patients before and 511 after the onset of the pandemic. The first occurrence of cardiovascular death, ischemic events, and myocardial infarction was higher during the COVID-19 pandemic than during the pre-pandemic period (P<0.05). During the pandemic, AAs experienced a significantly higher incidence of first ischemic events than non-AAs (P=0.03). Notably, AA men had significantly higher rates of ischemic events than AA women, non-AA men, and non-AA women during the COVID-19 pandemic (P<0.05).   Conclusions: These findings further emphasize the importance of addressing the increased thrombogenic risk among AAs, who exhibit higher ischemic risk than their non-AA counterparts. (Iranian Heart Journal 2024; 25(3): 35-50)
کلیدواژه‌های انگلیسی مقاله COVID-19,Percutaneous Coronary Intervention,African Americans,disparities
نویسندگان مقاله Sanchit Duhan |
Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, MD, USA.

Udaya S. Tantry |
Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, MD, USA.

Parshotam Kundan |
Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, MD, USA.

Naval Walia |
Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, MD, USA.

Juzer Ali Asgar |
Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, MD, USA.

Bijeta Keisham |
Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, MD, USA.

Kevin Bliden |
Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, MD, USA.

Charles Cummings |
Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, MD, USA.

Mohammed Abuzahra |
Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, MD, USA.

Paul A. Gurbel |
Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, MD, USA.

نشانی اینترنتی http://journal.iha.org.ir/article_199184_d586b1041821d38b10eb5302eed9c055.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات